Related Experiment Videos
Elastin point mutations cause an obstructive vascular disease, supravalvular aortic stenosis
1Cardiology Division, University of Utah Health Sciences Center, Eccles Institute of Human Genetics, Salt Lake City 84112, USA.
Human Molecular Genetics
|July 1, 1997
Summary
Supravalvular aortic stenosis (SVAS) is caused by mutations in the elastin gene (ELN). This study identifies point mutations in ELN as the primary cause of autosomal dominant SVAS, expanding on previous findings of larger DNA rearrangements.
Area of Science:
- Genetics
- Cardiovascular Medicine
- Molecular Biology
Background:
- Supravalvular aortic stenosis (SVAS) is an inherited obstructive vascular disease affecting major arteries.
- Previous research suggested elastin gene (ELN) mutations, specifically gross DNA rearrangements, caused SVAS.
- However, these rearrangements were not found in most autosomal dominant SVAS cases.
Purpose of the Study:
- To define the full spectrum of elastin gene (ELN) mutations responsible for supravalvular aortic stenosis (SVAS).
- To investigate the role of ELN point mutations in familial and sporadic SVAS cases.
Main Methods:
- Refined the genomic structure of the human elastin gene (ELN).
- Performed mutational analyses on familial and sporadic SVAS cases.
- Utilized co-segregation analysis to link mutations with the disease phenotype.
Main Results:
- Identified ELN point mutations co-segregating with SVAS in four familial cases.
- Associated ELN point mutations with SVAS in three sporadic cases.
- Characterized mutation types including nonsense, single base pair deletion, and splice site mutations, with one de novo mutation identified.
Conclusions:
- Point mutations in the elastin gene (ELN) are a significant cause of autosomal dominant supravalvular aortic stenosis (SVAS).
- This finding broadens the understanding of ELN's role in SVAS beyond previously identified gross DNA rearrangements.